ARTICLE | Clinical News
F. Hoffmann-La Roche regulatory update
October 31, 1994 8:00 AM UTC
F. Hoffmann-La Roche The European Committee for Proprietary Medicinal Products (CPMP) approved Roche's Roferon-A (Interferon alfa-2a) to treat chronic hepatitis C. Roche (Basel) said that an 1,800 p...